Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 558.29Cr 84Cr 76Cr 70Cr 63Cr 119.57Cr 7.82TCr 124.15Cr 845.98Cr 334.61Cr 4.22TCr 314.11Cr 307.5Cr 13TCr P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 645.75Cr 97Cr 88Cr 81Cr 73Cr 138.3Cr 9.05TCr 143.6Cr 978.52Cr 387.03Cr 4.88TCr 363.32Cr 355.67Cr 15TCr EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
66.81%
Yield 2024 *
-
Yield 2025 -
1 day-0.73%
1 week-7.26%
Current month-8.09%
1 month-9.51%
3 months-10.89%
6 months-16.19%
Current year-5.98%
1 week 4.03
Extreme 4.03000000
4.42
1 month 4.03
Extreme 4.03000000
4.64
Current year 4.03
Extreme 4.03000000
5.47
1 year 4.03
Extreme 4.03000000
5.92
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
22.19
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
21/09/20 Sell

Chairman

19,40,600 0.2495%
18/09/20 Sell

Director

36,70,000 0.4719%
18/09/20 Sell

Chairman

2,96,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-7.26%-31.95%-50.72% 84Cr
-1.13%-1.17%+38.55%+139.23% 1,26100Cr
-1.36%-0.74%+39.64%+86.06% 67TCr
-0.59%-0.36%+25.14%+111.73% 52TCr
-0.76%+1.10%+41.43%+70.96% 39TCr
-0.75%-3.16%+54.39%+40.90% 35TCr
-1.83%-0.89%+26.00%+58.48% 30TCr
-1.65%-0.59%+1.55%+34.52% 28TCr
-0.95%-1.57%+34.01%+72.55% 25TCr
+1.60%-0.36%+37.21%+125.66% 21TCr
Average -0.81%-1.08%+26.60%+68.94% 42TCr
Weighted average by Cap. -0.97%-0.55%+34.96%+95.65%

Financials

2024 2025
Net sales 382.54Cr 57Cr 52Cr 48Cr 43Cr 82Cr 5.36TCr 85Cr 579.66Cr 229.27Cr 2.89TCr 215.23Cr 210.7Cr 9.14TCr 304.86Cr 46Cr 42Cr 38Cr 35Cr 65Cr 4.27TCr 68Cr 461.96Cr 182.72Cr 2.3TCr 171.53Cr 167.91Cr 7.28TCr
Net income 3.36Cr 50.42L 45.77L 42.28L 38.14L 72.01L 47Cr 74.77L 5.09Cr 2.02Cr 25Cr 1.89Cr 1.85Cr 80Cr -10Cr -1.57Cr -1.42Cr -1.31Cr -1.18Cr -2.24Cr -146.23Cr -2.32Cr -16Cr -6.26Cr -79Cr -5.87Cr -5.75Cr -249.3Cr
Net Debt 140.03Cr 21Cr 19Cr 18Cr 16Cr 30Cr 1.96TCr 31Cr 212.19Cr 84Cr 1.06TCr 79Cr 77Cr 3.34TCr 87Cr 13Cr 12Cr 11Cr 9.92Cr 19Cr 1.23TCr 19Cr 132.54Cr 52Cr 661.28Cr 49Cr 48Cr 2.09TCr
Projected Income Statement - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
17/26/17 CN¥4.090 -0.73% 93,51,606
16/26/16 CN¥4.120 -2.83% 85,21,654
13/26/13 CN¥4.240 -2.97% 85,94,600
12/26/12 CN¥4.370 -1.13% 66,07,200
11/26/11 CN¥4.420 +0.23% 38,50,100

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002424 Stock